Shanghai Shen Lian Biomedical Corporation
688098StockSHG
8.53 ▲ +2.28%
15 juin 2026
6
Shanghai Shen Lian Biomedical Corporation
8.53 ▲ +2.28%
15 juin 2026
688098StockSHG

01 / À propos

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

Arberion
Loading market data